BFRI · Biofrontera Inc
United States · RS rating 16 · As of 2026-10-14
| Price | 0.83 USD |
|---|---|
| 1-day change | -7.0% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 6 / 14 / 31 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 31 / 39 |
| Industry group (rank) | Medical-Ethical Drugs (91) |
| EPS growth Q/Q | +178.1% |
| Sales growth Q/Q | +144.7% |
| Distance from 52-week high | +48.5% |
| Market cap (USD) | $12.0M |